Protection of bone mass by estrogens and raloxifene during exercise-induced weight loss

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 1, 2005, Pages 52-59

  Gozansky, W S ^a,b   Van Pelt, R E ^a   Jankowski, C M ^a   Schwartz, R S ^a   Kohrt, W M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Campus Box B179 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; RALOXIFENE;

ADULT; AGED; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; EXERCISE; FEMALE; FRAGILITY FRACTURE; HORMONAL THERAPY; HUMAN; LUMBAR SPINE; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; WEIGHT REDUCTION;

AGED; BODY COMPOSITION; BONE DENSITY; ESTROGENS; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; RALOXIFENE; WEIGHT LOSS;

EID: 12244264186     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0275     Document Type: Article

References (40)

1. Cummings SR, Bates D, Black DM 2002 Clinical use of bone densitometry: scientific review. JAMA 288:1889-1897
2. Lane JM, Russell L, Khan SN 2000 Osteoporosis. Clin Orthop 372:139-150
3. Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR 2002 Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol (Oxf) 56:703-711
4. Hui SL, Perkins AJ, Zhou L, Longcope C, Econs MJ, Peacock M, McClintock C, Johnston Jr CC 2002 Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels. J Clin Endocrinol Metab 87:1539-1543
5. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP 2000 Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 15:710-720
6. Sirola J, Kroger H, Honkanen R, Jurvelin JS, Sandini L, Tuppurainen MT, Saarikoski S 2003 Factors affecting bone loss around menopause in women without HRT: a prospective study. Maturitas 45:159-167
7. Sirola J, Kroger H, Honkanen R, Sandini L, Tuppurainen M, Jurvelin JS, Saarikoski S 2003 Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss? Osteoporos Int 14:27-33
8. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
9. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289:3243-3253
10. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D 2003 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: A randomized controlled trial. JAMA 289:2663-2672
11. Shumaker SA, Legault C, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones III BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J 2003 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662
12. American College of Obstetricians and Gynecologists 2002 ACOG committee opinion. Risk of breast cancer with estrogen-progestin replacement therapy. Int J Gynaecol Obstet 76:333-335
13. North American Menopause Society 2003 Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. Menopause 10:6-12
14. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, Schenck-Gustafsson K, Smith Jr SC, Taubert KA, Wenger NK 2001 Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 104:499-503
15. Williams DB, Voigt BJ, Fu YS, Schoenfeld MJ, Judd HL 1994 Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement. Obstet Gynecol 84:787-793
16. Racette SB, Weiss EP, Obert KA, Kohrt WM, Holloszy JO 2001 Modest lifestyle intervention and glucose tolerance in obese African Americans. Obes Res 9:348-355
17. Weir JB1949 New method for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9
18. Kohrt WM, Spina RJ, Holloszy JO, Ehsani AA 1998 Prescribing exercise intensity for older women. J Am Geriatr Soc 46:1-5
19. American College of Sports Medicine 2000 Guidelines for exercise testing and prescription, 6th Ed. Philadelphia: Lippincott Williams & Wilkins.
20. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, Nordin BE, Barrett-Connor E, Black D, Bonjour JP, Dawson-Hughes B, Delmas PD, Dequeker J, Ragi ES, Gennari C, Johnell O, Johnston Jr CC, Lau EM, Liberman UA, Lindsay R, Martin TJ, Masri B, Mautalen CA, Meunier PJ, Khaltaev N 1999 Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10:259-264
21. Pritchard JE, Nowson CA, Wark JD 1996 Bone loss accompanying diet-induced or exercise-induced weight loss: a randomised controlled study. Int J Obes Relat Metab Disord 20:513-520
22. Keller TS, Weisberger AM, Ray JL, Hasan SS, Shiavi RG, Spengler DM 1996 Relationship between vertical ground reaction force and speed during walking, slow jogging, and running. Clin Biomech 11:253-259
23. Lanyon LE 1996 Using functional loading to influence bone mass and architecture: objectives, mechanisms, and relationship with estrogen of the mechanically adaptive process in bone. Bone 18:37S-43S
24. Jensen LB, Quaade F, Sorensen OH 1994 Bone loss accompanying voluntary weight loss in obese humans. J Bone Miner Res 9:459-463
25. Chao D, Espeland MA, Farmer D, Register TC, Lenchik L, Applegate WB, Ettinger Jr WH 2000 Effect of voluntary weight loss on bone mineral density in older overweight women. J Am Geriatr Soc 48:753-759
26. Fogelholm GM, Sievanen HT, Kukkonen-Harjula TK, Pasanen ME 2001 Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women. Osteoporos Int 12:199-206
27. Ricci TA, Chowdhury HA, Heymsfield SB, Stahl T, Pierson RNJ, Shapses SA 1998 Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women. J Bone Miner Res 13:1045-1050
28. Jensen LB, Kollerup G, Quaade F, Sorensen OH 2001 Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation. J Bone Miner Res 16:141-147
29. Svendsen OL, Hassager C, Christiansen C 1993 Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. Am J Med 95:131-140
30. Ryan AS, Nicklas BJ, Dennis KE 1998 Aerobic exercise maintains regional bone mineral density during weight loss in postmenopausal women. J Appl Physiol 84:1305-1310
31. Svendsen OL, Hendel HW, Gotfredsen A, Pedersen BH, Andersen T 2002 Are soft tissue composition of bone and non-bone pixels in spinal bone mineral measurements by DXA similar? Impact of weight loss. Clin Physiol Funct Imaging 22:72-77
32. Kohrt WM 1998 Preliminary evidence that DEXA provides an accurate assessment of body composition. J Appl Physiol 84:372-377
33. Tothill P, Hannan WJ, Wilkinson S 2001 Comparisons between a pencil beam and two fan beam dual energy X-ray absorptiometers used for measuring total body bone and soft tissue. Br J Radiol 74:166-176
34. Tothill P, Hannen WJ 2000 Comparisons between Hologic QDR 1000W, QDR 450OA, and Lunar Expert dual-energy x-ray absorptiometry scanners used for measuring total body bone and soft tissue. Ann NY Acad Sci 904:63-71
35. Ricci TA, Heymsfield SB, Pierson RNJ, Stahl T, Chowdhury HA, Shapses SA 2001 Moderate energy restriction increases bone resorption in obese post-menopausal women. Am J Clin Nutr 73:347-352
36. Shapses SA, Von Thun NL, Heymsfield SB, Ricci TA, Ospina M, Pierson Jr RN, Stahl T 2001 Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res 16:1329-1336
37. Talbott SM, Cifuentes M, Dunn MG, Shapses SA 2001 Energy restriction reduces bone density and biomechanical properties in aged female rats. J Nutr 131:2382-2387
38. Burger HG 2001 Physiological principles of endocrine replacement: estrogen. Horm Res 56(Suppl 1):82-85
39. Fogelholm M, Sievanen H, Heinonen A, Virtanen M, Uusi-Rasi K, Pasanen M, Vuori I 1997 Association between weight cycling history and bone mineral density in premenopausal women. Osteoporos Int 7:354-358
40. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C 2002 Meta-analyses of therapies for postmenopausal osteoporosis. IX. Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570-578